HLA-C and cancer: However, considering that human ESCs were injected into mice, there was the possibility that the aforementioned immune responses were due to the incompatibility of the MHC antigens between the human ESCs and mouse cells rather than the ESC lines [169]; moreover, the tumorigenicity induced by the ESCs hampered their usage as effective cancer vaccines for clinical applications [171,172,173].